enow.com Web Search

Search results

  1. Results from the WOW.Com Content Network
  2. International Science and Engineering Fair - Wikipedia

    en.wikipedia.org/wiki/International_Science_and...

    The Regeneron International Science and Engineering Fair (ISEF) is an annual science fair in the United States. [1] It is owned and administered by the Society for Science, [2] a 501(c)(3) non-profit organization based in Washington, D.C. [3] Each May, more than 1800 students from roughly 75 countries and territories compete in the fair for scholarships, tuition grants, internships, scientific ...

  3. Talk:International Science and Engineering Fair - Wikipedia

    en.wikipedia.org/wiki/Talk:International_Science...

    1 The Regeneron International Science and Engineering Fair (ISEF) is an annual science fair in the United States.[1] It is owned and administered by the Society for Science,[2] a 501(c)(3) non-profit organization based in Washington, D.C.[3] Each May, more than 1500 students from roughly 70 countries and territories compete in the fair for scholarships, tuition grants, internships, scientific ...

  4. Regeneron Science Talent Search - Wikipedia

    en.wikipedia.org/wiki/Regeneron_Science_Talent...

    The Regeneron Science Talent Search, known for its first 57 years [1] as the Westinghouse Science Talent Search, and then as the Intel Science Talent Search (Intel STS) from 1998 through 2016, [2] is a research-based science competition in the United States for high school seniors.

  5. Regeneron Pharmaceuticals - Wikipedia

    en.wikipedia.org/wiki/Regeneron_Pharmaceuticals

    Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York.The company was founded in 1988. [2] Originally focused on neurotrophic factors and their regenerative capabilities, giving rise to its name, the company branched out into the study of both cytokine and tyrosine kinase receptors, which gave rise to their first product, which is a ...

  6. Regeneron's blood cancer therapy faces setback as FDA ... - AOL

    www.aol.com/news/regenerons-blood-cancer-therapy...

    (Reuters) -Regeneron Pharmaceuticals said on Monday the U.S. FDA has declined approval for its blood cancer therapy for two forms of lymphoma on concerns over the progress of ongoing confirmatory ...

  7. US FDA declines to approve Regeneron's blood cancer therapy - AOL

    www.aol.com/news/us-fda-declines-approve...

    Regeneron was seeking regulatory approval of its therapy, linvoseltamab, in patients with multiple myeloma whose cancer has returned or worsened after at least three prior lines of treatment. The ...

  8. Therapeutic drug monitoring - Wikipedia

    en.wikipedia.org/wiki/Therapeutic_drug_monitoring

    Therapeutic drug monitoring (TDM) is a branch of clinical chemistry and clinical pharmacology that specializes in the measurement of medication levels in blood. Its main focus is on drugs with a narrow therapeutic range , i.e. drugs that can easily be under- or overdosed. [ 1 ]

  9. US FDA approves higher dose of Regeneron's eye disease drug Eylea

    www.aol.com/news/us-fda-approves-higher-dose...

    The drug, Eylea HD, is priced at $2,625 per single-use vial in the U.S. and is used to treat patients with wet age-related macular degeneration (AMD), diabetic macular edema (DME) and diabetic ...